We are live on ! Find out more
TSS

Two Sigma Securities Portfolio holdings

AUM $861M
1-Year Est. Return 21.33%
This Fund
S&P 500
This Quarter Est. Return
+3.5%
1 Year Est. Return
+21.33%
3 Year Est. Return
+86.85%
5 Year Est. Return
+97.02%
10 Year Est. Return
+293.06%
AUM
$8.28B
AUM Growth
-$2.08B
Cap. Flow
-$2.16B
Cap. Flow %
-26.12%
Top 10 Hldgs %
11.07%
Holding
3,887
New
1,000
Increased
869
Reduced
1,033
Closed
963

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$71.1M
2
LLY icon
Eli Lilly
LLY
+$26.4M
3
ACN icon
Accenture
ACN
+$25M
4
AVGO icon
Broadcom
AVGO
+$16.3M
5
BAC icon
Bank of America
BAC
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 7.72%
2 Consumer Discretionary 2.89%
3 Healthcare 2.83%
4 Communication Services 2.59%
5 Financials 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAIH
3801
SAIHEAT Ltd
SAIH
$26.8M
-895
Closed -$15.6K
PVLA
3802
Palvella Therapeutics
PVLA
$1.98B
-728
Closed -$10.7K
PHLT
3803
DELISTED
Performant Healthcare Inc
PHLT
-10,753
Closed -$31.6K
JXG
3804
JX Luxventure
JXG
$84.4M
-323
Closed -$23.5K
LAR
3805
Lithium Argentina AG
LAR
$958M
-18,131
Closed -$97.7K
SGI
3806
CALL
Somnigroup International
SGI
$15.1B
-3,600
Closed -$205K
SGI
3807
Somnigroup International
SGI
$15.1B
-9,149
Closed -$520K
QVCGA
3808
DELISTED
QVC Group Inc Series A
QVCGA
-969
Closed -$59.6K
CTEV
3809
Claritev Corp
CTEV
$368M
-1,074
Closed -$34.9K
FNGA
3810
DELISTED
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038
FNGA
-1,510
Closed -$494K
NAGE
3811
Niagen Bioscience
NAGE
$256M
-19,851
Closed -$69.1K
TVRD
3812
Tvardi Therapeutics
TVRD
$23.5M
-305
Closed -$9.99K
SPRB
3813
Spruce Biosciences
SPRB
$119M
-347
Closed -$20.4K
CMRX
3814
DELISTED
Chimerix, Inc.
CMRX
-11,000
Closed -$11.7K
SYRA
3815
DELISTED
Syra Health Corp. Class A Common Stock
SYRA
-10,545
Closed -$14.6K
NVRO
3816
CALL
DELISTED
NEVRO CORP.
NVRO
-19,800
Closed -$286K
NVRO
3817
PUT
DELISTED
NEVRO CORP.
NVRO
-12,300
Closed -$178K
DM
3818
DELISTED
Desktop Metal, Inc.
DM
-3,438
Closed -$30.3K
ACHL
3819
DELISTED
Achilles Therapeutics
ACHL
-16,312
Closed -$20.4K
ATXI
3820
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
-2,374
Closed -$26.3K
HCP
3821
CALL
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
-13,100
Closed -$353K
HCP
3822
PUT
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
-9,800
Closed -$264K
NKLA
3823
DELISTED
Nikola Corporation Common Stock
NKLA
-460
Closed -$14.3K
CTV
3824
DELISTED
Innovid Corp.
CTV
-14,184
Closed -$35.3K
NMHIW
3825
DELISTED
Natures Miracle Holding Inc. Warrants
NMHIW
-11,324
Closed -$906

Similar funds

Two Sigma Securities's Q2 2024 Portfolio in Review

As of Q2 2024, Two Sigma Securities held 3,887 positions worth $8.28B, down 20% from $10.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Two Sigma Securities withdrew a net $2.16B in Q2 2024, closing 963 positions and reducing 1,033 holdings. Its most notable exit was Nike, an estimated $17.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, up from 6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Two Sigma Securities opened a new position in Accenture worth $24.8M.

  • Two Sigma Securities's largest Q2 2024 buy was Accenture: 81,773 shares worth $24.8M.
  • Two Sigma Securities added most to NVIDIA in Q2 2024, an estimated $71.1M increase.
  • Two Sigma Securities's biggest Q2 2024 reduction was Amazon, cutting an estimated $55.1M.
  • Two Sigma Securities fully exited Nike in Q2 2024, selling an estimated $17.5M.
  • Two Sigma Securities's ten largest holdings make up 11% of its $8.28B portfolio in Q2 2024.
  • Two Sigma Securities opened 1,000 new positions and closed 963 in Q2 2024.
  • Two Sigma Securities's portfolio value fell 20% quarter-over-quarter to $8.28B.

Based on Two Sigma Securities's 13F filing for Q2 2024, filed 14 Aug 2024.